These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 16364678

  • 1. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
    Acay RR, Felizzola CR, de Araújo N, de Sousa SO.
    Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
    [Abstract] [Full Text] [Related]

  • 2. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients.
    van der Meij EH, Mast H, van der Waal I.
    Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA, Paradella TC, Carvalho YR, Rosa LE.
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R, Alanen K, Syrjänen S.
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [Abstract] [Full Text] [Related]

  • 5. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
    Safadi RA, Al Jaber SZ, Hammad HM, Hamasha AA.
    Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
    [Abstract] [Full Text] [Related]

  • 6. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ, Kuo MY, Cheng SJ, Chiang CP, Jeng JH, Chang HH, Kuo YS, Lan WH, Kok SH.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [Abstract] [Full Text] [Related]

  • 7. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study.
    van der Meij EH, Schepman KP, van der Waal I.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Aug; 96(2):164-71. PubMed ID: 12931088
    [Abstract] [Full Text] [Related]

  • 8. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM, Björnsson J, Holbrook WP.
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [Abstract] [Full Text] [Related]

  • 9. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review.
    Fitzpatrick SG, Hirsch SA, Gordon SC.
    J Am Dent Assoc; 2014 Jan; 145(1):45-56. PubMed ID: 24379329
    [Abstract] [Full Text] [Related]

  • 10. High percentage of oral lichen planus and lichenoid lesion in oral squamous cell carcinomas.
    Ruokonen HMA, Juurikivi A, Kauppila T, Heikkinen AM, Seppänen-Kaijansinkko R.
    Acta Odontol Scand; 2017 Aug; 75(6):442-445. PubMed ID: 28562162
    [Abstract] [Full Text] [Related]

  • 11. p53 expression in oral lichenoid lesions and oral lichen planus.
    Arreaza A, Rivera H, Correnti M.
    Gen Dent; 2015 Aug; 63(1):69-72. PubMed ID: 25574723
    [Abstract] [Full Text] [Related]

  • 12. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM, Hemavathy S.
    Indian J Dent Res; 2011 Aug; 22(4):520-5. PubMed ID: 22124045
    [Abstract] [Full Text] [Related]

  • 13. Expression of Fas/FasL in patients with oral lichen planus.
    Hadzi-Mihailovic M, Raybaud H, Monteil R, Jankovic L.
    J BUON; 2009 Aug; 14(3):487-93. PubMed ID: 19810143
    [Abstract] [Full Text] [Related]

  • 14. Lichenoid dysplasia revisited - evidence from a review of Indian archives.
    Patil S, Rao RS, Sanketh DS, Warnakulasuriya S.
    J Oral Pathol Med; 2015 Aug; 44(7):507-14. PubMed ID: 25224597
    [Abstract] [Full Text] [Related]

  • 15. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I.
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [Abstract] [Full Text] [Related]

  • 16. Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002-2011.
    Casparis S, Borm JM, Tektas S, Kamarachev J, Locher MC, Damerau G, Grätz KW, Stadlinger B.
    Oral Maxillofac Surg; 2015 Jun; 19(2):149-56. PubMed ID: 25308326
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of cyclooxygenase-2 as a biomarker in different subtypes of the oral lichenoid disease.
    Cortés-Ramírez DA, Rodríguez-Tojo MJ, Gainza-Cirauqui ML, Martínez-Conde R, Aguirre-Urizar JM.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):738-43. PubMed ID: 21112532
    [Abstract] [Full Text] [Related]

  • 18. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: an immunohistochemical study.
    Zargaran M, Jamshidi S, Eshghyar N, Moghimbeigi A.
    Asian Pac J Cancer Prev; 2013 Dec; 14(11):6979-83. PubMed ID: 24377636
    [Abstract] [Full Text] [Related]

  • 19. Oral lichenoid dysplasia and not oral lichen planus undergoes malignant transformation at high rates.
    Shearston K, Fateh B, Tai S, Hove D, Farah CS.
    J Oral Pathol Med; 2019 Aug; 48(7):538-545. PubMed ID: 31172588
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of oral lichen planus. A premalignant lesion?
    Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP.
    Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.